FdaApplication

ANDA 217334

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVITIUM PHARMA LLC
application_typeANDA
approval_date2023-09-06

Products (3)

ProductActive ingredientStrengthDosage form
ESTRADIOLESTRADIOL2MGTABLET;ORAL
ESTRADIOLESTRADIOL1MGTABLET;ORAL
ESTRADIOLESTRADIOL0.5MGTABLET;ORAL

3 products